Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation

Cancer Research

Volumn 56, Issue 7, 1996, Pages 1509-1511

  Yang, Xiao Feng ^a   Beamer, Wesley G ^b   Huynh, Hung ^a   Pollak, Michael ^a  

^a MCGILL UNIVERSITY   (Canada)

^b JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER GROWTH; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; MISSENSE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; TARGET CELL; TUMOR XENOGRAFT;

ANIMALS; FEMALE; GROWTH HORMONE; HOMOZYGOTE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, SCID; MUTATION; NEOPLASM TRANSPLANTATION; RECEPTORS, NEUROPEPTIDE; RECEPTORS, PITUITARY HORMONE-REGULATING HORMONE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0029976435     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Juul, A., Bang, P., Hertel, N., et al. Serum insulin-like growth factor I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J. Clin. Endocrinol. Metab., 78: 744-752, 1995.
2. Pollak, M., Costantino, J., Polychronakos, C., Blauer, S , Guyda, H., Redmond, C., Fisher, B , and Margolese, R. Effect of tamoxifen on serum insulin-like growth factor I levels in stage 1 breast cancer patients. J. Natl Cancer Inst., 82: 1693-1697, 1990.
3. Stoll, B. Breast cancer risk in Japanese women with special reference to the growth hormone-insulin-like growth factor axis. Jpn. J. Clin Oncol., 22: 1-5, 1992.
4. deWaard, F., Cornelis, J , Aoki, K , and Yoshida, M. Breast cancer incidence according to weight and height in two cities of the Netherlands and in Aichi prefecture. Jpn. Cancer, 40: 1269-1275, 1995.
5. Vatten, L., Kvikstad, A , and Nymoen, E. Incidence and mortality of breast cancer related to body height and living conditions during childhood and adolescence. Eur. J Cancer, 28: 128-131, 1992.
6. Murata, M., Kuno, K., and Sakamoto, G. Epidemiology of family predisposition for breast cancer in Japan. J. Natl. Cancer Inst., 69, 1229-1234, 1982.
7. Tretli, S. Height and weight in relation to breast cancer morbidity and mortality. A prospective study of 570,000 women in Norway Int. J. Cancer, 44: 23-30, 1989.
8. Vatten, L. J., and Kvinnsland, S. Body height and risk of breast cancer. A prospective study of 23,831 Norwegian women. Br. J. Cancer. 61, 881-885, 1990.
9. Mondina, R , Borsellino, G., Poma, S., Baroni, M , Di Nubila, B., and Sacchi, P. Breast carcinoma and skeletal formation. Eur J. Cancer, 28A: 1068-1070, 1992
10. Hunter, D., and Willett, W. Diet, body size, and breast cancer. Epidemiol. Rev., 15: 110-132, 1993.
11. Shiu, R., and Paterson, J. Alteration of cell shape, adhesion, and lipid accumulation in human breast cancer cells by human prolactin and growth hormone. Cancer Res., 44. 1178-1186, 1984
12. Pollak, M , Polychronakos, C., Yousefi, S , and Richard, M. Characterization of insulin-like growth factor (IGF-I) receptors of human breast cancer cells. Biochem. Biophys. Res. Commun., 154: 326-331, 1988.
13. Arteaga, C L., and Osborne, C. K. Growth inhibition of human breast cancer cells in vitro with an antibody against the type 1 somatomedin receptor. Cancer Res., 49: 6237-6241, 1989.
14. Arteaga, C. L., Kitten, L. J., Coronado, E. B., Jacobs, S., Kull, F. C , Allred, D. C., and Osborne, C. K. Blockade of the type 1 somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J. Clin. Invest., 84: 1418-1423, 1989.
15. Yee, D., Paik, S. Lebovic, G. S., Marcus, R. R., Favoni, R. E. Cullen, K. J., Lippman, M. E., and Rosen, N. Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol. Endocrinol., 3: 517-519, 1989.
16. Schuler, W., and Bosma, M. J. Nature of the seid defect: a defective VDJ recombinase system Curr. Top Microbiol. Immunol., 152. 55-62, 1989.
17. Eicher, E., and Beamer, W. Inherited ateliotic dwarfism in mice. Characteristics of the mutation, little, on chromosome 6 Journal of Heredity, 67. 87-91, 1976.
18. Jansson, J. O , Downs, T. R , Beamer, W. G., and Frohman, L. A. Receptor-associated resistance to growth hormone-releasing factor in dwarf "little" mice. Science (Washington DC), 232: 511-512, 1986.
19. Godfrey, P., Rahal, J O., Beamer, W. G., Copeland, N. G , Jenkins, N. A., and Mayo, K E. GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat. Genet., 4: 227-232, 1993.
20. Lin, S C., Lin, C. R., Gukovsky, I., Lusis, A. J , Sawchenko, P. E., and Rosenfeld, M. G. Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature (Lond), 364: 208-213, 1993.
21. Wajnrajch, M P., Gertner, J M , Harbison, M D., Chua, S C., and Leibel, R. L. Nonsense mutation in the human growth hormone releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nat Genet., 12: 88-90, 1996
22. Bang, P , Baxter, R C., Blum, W. F , Breier, B. H , Clemmons, D. R., Hall, K , Hintz, R. L., Holly, J M., Rosenfeld, R. G., and Zapf, J. Valid measurements of total IGF concentrations in biological fluids Recommendations from the 3rd International Symposium on Insulin-like Growth Factors. Endocrinology, 136. 816-817, 1995.
23. Tannenbaum, G. S., Gurd, W., Lapointe, M , and Pollak, M. Tamoxifen attenuates pulsatile growth hormone secretion: mediation in part by somatostatin. Endocrinology, 130: 3395-3401, 1992
24. Huynh, H. T., Tetenes, E., Wallace, L., and Pollak, M. In vivo inhibition of insulin-like growth factor-I gene expression by tamoxifen. Cancer Res., 53: 1727-1730, 1993
25. Zarandi, M., Horvath, J E., Halmos, G., Pinski, J., Nagy, A., Groot, K., Rekasi, Z., and Schally, A. V. Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone Proc. Natl. Acad. Sci USA, 91: 12298-12302, 1994.
26. Huynh, H. T., and Pollak, M. Enhancement of tamoxifen-induced suppression of insulin-like growth factor I gene expression and serum level by a somatostatin analogue. Biochem Biophys. Res Commun., 203. 253-259, 1994.
27. Weckbecker, G., Tolcsvai, L., Stolz, B., Pollak, M., and Bruns, C. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas. Cancer Res , 54: 6334-6337, 1994.
28. Chen, W. Y., Chen, N. Y., Yum, J , Washer, T E , and Kopchick, J. J. In vitro and in vivo studies of antagonistic effects of human growth hormone analogues. J. Biol. Chem , 269: 15892-15897, 1994.
29. Pietrzkowski, Z., Wernicke, D , Porcu, P., Jameson, B A , and Basensa, R. Inhibition of cellular proliferation by peptide analogs of IGF-I. Cancer Res., 52: 6447-6451, 1992.
30. Ray, B S , and Pearson, O. H. Hypophysectomy in treatment of disseminated breast cancer. Surg. Clin North Am , 12. 419-433, 1962.
31. Liu, J P., Baker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor (IGF-1) and type 1 IGF receptor (IGF1r). Cell, 75: 59-72, 1993
32. Peyrat, J P., Bonneterre, J , Hecquet, B., Vennin, P., Louchez, M. M., Fournier, C., Lefebvre, J , and Demaille, A Plasma insulin-like growth factor-1 (IGF-1) concentration in human breast cancer. Eur J. Cancer, 29A: 492-497, 1993.
33. Ruggeri, B , Klurfeld, D., Kritchevsky, D., and Furlanetto, R Caloric restriction and DMBA-induced mammary tumor growth in rats: alternations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor. Cancer Res., 49: 4130-4134, 1989